Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-18 · accession 0001493152-22-033241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-22 | 2022-11-18+ | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $1.89 | +10.0K | 75.4K | +15% | +$18.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-11-18 | P | A | 400 | $1.76 | 65,774 | D | — | — | |
| 2 | Common | Common stock | 2022-11-21 | P | A | 9,600 | $1.90 | 75,374 | D | — | — |